KRONOX LAB SCIENCES LTD
NSE: KRONOXMarket Closed • NSE
Day range
52 week range
KRONOX LAB SCIENCES LTD closed at INR209.15 (-4.14%) on volume 0.71x its 20-day average, trading 8.16% below its 52-week high.
2026-Q1
Q1 FY2026 Financial Results
PAT moved +21.4% QoQ
2026-09-09
DIVIDEND Announced
Dividend - Re 0.50 Per Share
2025-08-08
DIVIDEND Announced
Dividend - Rs 0.50 Per Share
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Established operational history in the sector
Active institutional participation
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Specialty Chemicals.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 09 Sept 2026 | Dividend | ₹0.50 / share | — | 09 Sept 2026 |
| 08 Aug 2025 | Dividend | ₹0.50 / share | — | 08 Aug 2025 |
| — | Dividend | ₹0.50 / share | — | 23 Aug 2024 |
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 UltraTech Cement LimitedULTRACEMCO Open analysis | ₹3.21L | 37.59 | 2.21% | ₹25,799.47 | ₹2,982.76 | +11.86% | +20.17% |
 JSW Steel LimitedJSWSTEEL Open analysis | ₹2.97L | 12.05 | 0.59% | ₹47,364.00 | ₹4,651.00 | +11.55% | +112.96% |
 Hindustan Zinc LimitedHINDZINC Open analysis | ₹2.28L | 13.37 | 2.07% | ₹13,687.00 | ₹5,425.00 | +77.22% | +146.14% |
 Asian Paints LimitedASIANPAINT Open analysis | ₹2.24L | 46.94 | 1.17% | ₹10,541.94 | ₹1,539.25 | +17.94% | +39.96% |
 Tata Steel LimitedTATASTEEL Open analysis | ₹2.19L | 19.83 | 2.27% | ₹60,794.00 | ₹2,385.00 | +14.32% | +18.83% |
 Hindalco Industries LimitedHINDALCO Open analysis | ₹2.02L | 12.32 | 0.56% | ₹84,825.00 | ₹7,013.00 | +32.06% | +75.15% |
 Grasim Industries LimitedGRASIM Open analysis | ₹1.98L | 34.82 | 0.35% | ₹11,794.71 | ₹246.65 | -70.60% | -82.61% |
 Solar Industries India LimitedSOLARINDS Open analysis | ₹1.81L | 90.93 | 0.06% | ₹3,668.00 | ₹666.00 | +70.29% | +88.67% |
Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, such as tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, custom specification, and specialty anhydrous, as well as heat treatment, quenching, eutectic salt. Kronox Lab Sciences Limited was incorporated in 2008 and is based in Vadodara, India.
IndiaBasic Materials
Is KRONOX LAB SCIENCES LTD Shariah compliant?
KRONOX LAB SCIENCES LTD is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (0.21%) complies with AAOIFI threshold (≤ 33%).
What is KRONOX LAB SCIENCES LTD's current valuation relative to peers?
KRONOX LAB SCIENCES LTD trades at a P/E of 27.1x compared to the sector median of 21.9x, and a Price-to-Book of 6.6x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 1.38x. Interest coverage is 282.7x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at steady rates while net profit growth averaged consistent levels.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.